Steven Dubois
Pediatric Hematology-Oncology · Boston, MANPI 1992746911
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Pfizer at 33.1% of the total. Reporting peaked in 2019 at $23,638 and has fallen 90.5% since, to $2,240 in 2025. Among pediatric hematology-oncology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $1643.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$15K
- F. Hoffmann-la Roche AG$9K
- EMD Serono Research & Development Institute, Inc.$6K
- Bayer$5K
- Amgen$4K
- Jazz Pharmaceuticals Inc.$3K
- plus $2K from 2 others
Across 161 payments — averaging $19,543 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$2.2M
- Eisai Inc.$429K
- Merck$290K
- Bayer$132K
- Novartis$79K
- Eli Lilly$22K
What the payments were for
- Consulting fees$20,73247%
- Speaking & faculty fees$14,68033%
- Travel & lodging$8,44919%
- Food & beverage$5091%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 11 | $14,680 |
| F. Hoffmann-la Roche AG | 3 | $8,787 |
| EMD Serono Research & Development Institute, Inc. | 1 | $6,390 |
| Bayer | 3 | $5,328 |
| Amgen | 2 | $3,894 |
| Jazz Pharmaceuticals Inc. | 1 | $2,880 |
| Merck | 2 | $2,240 |
| EUSA Pharma (US) LLC | 4 | $171 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUTENT$14,680
- Non-Covered Product$8,787
- Vitrakvi$5,328
- ZEPZELCA$2,880
How this compares
$44,370 in reported general payments places this provider in the 90th percentile of 114 pediatric hematology-oncology providers in Massachusetts.
See all pediatric hematology-oncology providers in Massachusetts →
Other pediatric hematology-oncology in Boston
- Leslie KeanBoston$558K
- Todd GolubBoston$213K
- Rachael GraceBoston$201K
- Stacy CroteauBoston$117K
- Matthew HeeneyBoston$101K
- Susan PerrineBoston$96K
- Christine DuncanBoston$89K
- Eric GrabowskiBoston$56K
- Derek HansonBoston$54K
- Susan ParsonsBoston$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.